These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6886975)

  • 21. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A minimax approach to the single-point method of drug dosing.
    Bahn MM; Landaw EM
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):255-69. PubMed ID: 3668803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating bioavailability when clearance varies with time.
    Karlsson MO; Sheiner LB
    Clin Pharmacol Ther; 1994 Jun; 55(6):623-37. PubMed ID: 8004879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry.
    Tang H; Mayersohn M
    J Pharm Sci; 2006 Aug; 95(8):1783-99. PubMed ID: 16795013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.
    Wagner JG
    Eur J Clin Pharmacol; 1976; 10(6):425-32. PubMed ID: 1001358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
    Paixão P; Gouveia LF; Morais JA
    Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for estimating within-individual variability in clearance and in volume of distribution from standard bioavailability studies.
    Upton RA; Thiercelin JF; Moore JK; Riegelman S
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):135-46. PubMed ID: 7120044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics.
    Karalis V; Tsantili-Kakoulidou A; Macheras P
    Pharm Res; 2002 Dec; 19(12):1827-34. PubMed ID: 12523661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
    Wagner JG; Szpunar GJ; Ferry JJ
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):73-92. PubMed ID: 4020623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of baclofen derived from intestinal infusion.
    Kochak GM; Rakhit A; Wagner WE; Honc F; Waldes L; Kershaw RA
    Clin Pharmacol Ther; 1985 Sep; 38(3):251-7. PubMed ID: 4028618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion.
    Chan KK; Gibaldi M
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):551-8. PubMed ID: 7166738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the volume of distribution at steady state and its relationship with two-compartmental models.
    Yates JW; Arundel PA
    J Pharm Sci; 2008 Jan; 97(1):111-22. PubMed ID: 17705153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.
    Thomas G; Girre C; Scherrmann JM; Francheteau P; Steimer JL
    Eur J Clin Pharmacol; 1989; 37(1):79-84. PubMed ID: 2591469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamine.
    Gombar CT; Harrington GW; Pylypiw HM; Anderson LM; Palmer AE; Rice JM; Magee PN; Burak ES
    Cancer Res; 1990 Jul; 50(14):4366-70. PubMed ID: 2364390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The physiological significance of total body clearance in pharmacokinetic studies.
    Chiou WL
    J Clin Hosp Pharm; 1982 Mar; 7(1):25-30. PubMed ID: 7096575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.